The Middle East & Africa High Potency Active Pharmaceutical Ingredients Market size was valued at USD 1.31 billion in 2022. It is further estimated to be growing at a CAGR of 8.1% and worth USD 1.93 billion by 2027.
High Potency Active Pharmaceutical Ingredients (HPAPI) are pharmacological intermediates or substances active at concentrations below 150 micrograms per kilogram of body weight. They are characterized by a high degree of specificity and can bind to specific receptors or enzymes, which can cause cancer, reproductive problems, and developmental disorders at low doses. New drugs that are being released into the market have these high potency active pharmaceutical ingredients, leading to this market's high growth.
High Potency Active Pharmaceutical Ingredients have a new range of effective medicines to treat cancer and other hazardous diseases. After the human genome mapping was done, cancer drugs were made not only for different patients but also for different cancers. However, the production of these drugs is difficult since they are active at deficient concentrations. They can pose health problems to workers if they aren’t handled with care. Attentive monitoring has to be done to prevent contamination of drugs with foreign substances, requiring specialized equipment for managing air quality and handling HPAPI’s.
The driving factors of the Middle East and Africa's High Potency Active Pharmaceutical Ingredients market are their low price, rising healthcare prices, a growing number of pharmaceutical manufacturers and patients, and government initiatives to expand the usage of generic medicines to cut down healthcare costs.
This market's restraints are the high price of equipment, stringent regulatory requirements, and lack of skilled workers.
This research report on the Middle East and Africa HPAPI Market has been segmented and sub-segmented into the following categories:
By Type:
By Synthesis:
By Therapeutic Application:
By Country:
Geographically, the market is still in its emergent stages in the region. Factors such as increasing incidence of cancer, increasing research in cancer cures, and approvals for the production of new drugs will drive the market in this region.
Companies dominating the Middle East & Africa High Potency Active Pharmaceutical Ingredients Market profiled in the report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Innovative HPAPI's
5.1.2 Generic HPAPI's
5.1.3 Y-o-Y Growth Analysis, By Type
5.1.4 Market Attractiveness Analysis, By Type
5.1.5 Market Share Analysis, By Type
5.2 Synthesis
5.2.1 Biotech HPAPI's
5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type
5.2.1.1.1 Innovative Biotech HPAPIs
5.2.1.1.2 Biosimilars
5.2.2 Synthetic HPAPI's
5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type
5.2.2.1.1 Innovative Synthetic HPAPIs
5.2.2.1.2 Generic Synthetic HPAPIs
5.2.3 Y-o-Y Growth Analysis, By Synthesis
5.2.4 Market Attractiveness Analysis, By Synthesis
5.2.5 Market Share Analysis, By Synthesis
5.3 Therapeutic Application
5.3.1 Oncology
5.3.2 Glaucoma
5.3.3 Hormonal Balance
5.3.4 Other therapeutic applications
5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application
5.3.6 Market Attractiveness Analysis, By Therapeutic Application
5.3.7 Market Share Analysis, By Therapeutic Application
5.4 Manufacturer
5.4.1 Captive Manufacturers
5.4.2 Merchant Manufacturers
5.4.2.1 Merchant HPAPI Manufacturers Market, By Type
5.4.2.1.1 Innovative Merchant HPAPI Manufacturers
5.4.2.1.2 Generic Merchant HPAPI Manufacturers
5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis
5.4.2.2.1 Synthetic HPAPIs
5.4.2.2.2 Biotech HPAPIs
5.4.3 Y-o-Y Growth Analysis, By Manufacturer
5.4.4 Market Attractiveness Analysis, By Manufacturer
5.4.5 Market Share Analysis, By Manufacturer
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Type
6.1.3.2 By Synthesis
6.1.3.3 By Therapeutic Application
6.1.3.4 By Manufacturer
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Type
6.1.4.2 By Synthesis
6.1.4.3 By Therapeutic Application
6.1.4.4 By Manufacturer
6.1.5 Market Share Analysis
6.1.5.1 By Type
6.1.5.2 By Synthesis
6.1.5.3 By Therapeutic Application
6.1.5.4 By Manufacturer
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Service
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
